Franklin Templeton's Alternatives Push Is Turning Into Organic Growth, UBS Says

MT newswire2026/10/07 16:59

12:59 PM EDT, 10/07/2026 (MT Newswires) -- Franklin Templeton's (BEN) years of investment in alternatives, separately managed accounts and active exchange-traded funds are starting to deliver organic growth and wider margins, which should support more durable earnings, UBS said in a note emailed Wednesday. The bank said the asset manager is on track for positive organic growth in fiscal 2026 for the first time in over a decade, with private markets strength offsetting legacy active outflows. UBS also expects operating margins to keep expanding, supported by expense discipline, operating leverage and a growing contribution from higher-margin private assets. The bank assumed coverage on the stock with a buy rating and $40 per share price target. Price: 32.50, Change: +0.05, Percent Change: +0.17

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

B. Riley raises IMAX target price to $64

格隆汇•2026/10/12 02:39

Cantor Fitzgerald raises Merck target price to $145

格隆汇•2026/10/12 02:35

Saudi-led coalition says it intercepted Houthi ballistic missile toward Khamis Mushait

FXStreet•2026/10/12 02:15

Oppenheimer raises Humana's target price to $475

格隆汇•2026/10/12 02:15